Clinical Trials on Hormone-resistant Prostate Cancer in New Zealand
Total 2323 results
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); AbbVie; Rutgers Cancer Institute of New JerseyTerminated
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Terminated
-
Janssen Research & Development, LLCActive, not recruitingCastration-Resistant Prostatic CancerUnited States, China, Italy, Korea, Republic of, Taiwan, Australia, Sweden, Belgium, Canada, France, Hungary, Israel, Malaysia, Russian Federation, Portugal, Germany, Bulgaria, Spain, Netherlands, Turkey, United Kingdom, Ukraine, Po... and more
-
National Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Adenocarcinoma AJCC v7 | Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Prostate Adenocarcinoma With Neuroendocrine...United States
-
Weill Medical College of Cornell UniversityTerminated
-
NYU Langone HealthCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
Columbia UniversityGenentech, Inc.TerminatedProstate CancerUnited States
-
Matthew GalskyCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
NYU Langone HealthTrod Medical N.V.CompletedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
NYU Langone HealthTerminated
-
NYU Langone HealthDendreonTerminatedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
Icahn School of Medicine at Mount SinaiTerminatedProstate CancerUnited States
-
St. Luke's-Roosevelt Hospital CenterTerminatedProstate CancerUnited States
-
NYU Langone HealthNovartisTerminatedProstatic Neoplasms | Prostate CancerUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Momotaro-Gene Inc.Icahn School of Medicine at Mount SinaiWithdrawn
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Yale UniversityRecruitingProstate CancerUnited States
-
Maimonides Medical CenterCompleted
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Terminated
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate CancerUnited States, Guam
-
Weill Medical College of Cornell UniversityVarian Medical SystemsCompletedBreast Cancer | Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingGynecologic Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage III Breast Cancer | Stage III Gynecologic Cancer | Stage III Colorectal Cancer | Stage I Colorectal Cancer | Stage II Colorectal Cancer | Stage I Gynecologic... and other conditionsUnited States
-
Mark SteinRecruitingRecurrent Prostate CancerUnited States
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting
-
AstraZenecaActive, not recruitingHormone-Sensitive Prostate CancerUnited States, Belgium, Spain, Canada, Poland, Argentina, India, Taiwan, Thailand, Vietnam, Turkey, Russian Federation, France, Germany, Korea, Republic of, Brazil, Mexico, Peru, Philippines, China, United Kingdom, Hong Kong, Israel, ... and more
-
SonaCare MedicalUnknownRecurrent Prostate CancerUnited States, Canada
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Head and Neck Cancer | Prostate CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Stony Brook UniversityProgenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Royal North Shore HospitalCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompleted
-
Department of Veterans Affairs, New JerseyPfizerUnknownA Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerProstate CancerUnited States